在甲基胺使用障碍中,大脑衰老的结构指数
Johannes Petzold1, Jean-Baptiste F Pochon2, Dara G Ghahremani2
1Jane and Terry Semel Institute of Neuroscience and Human Behavior, and Department of Psychiatry and Biobehavioral Sciences, University of California at Los Angeles, Los Angeles, CA, USA; Department of Psychiatry and Psychotherapy, Carl Gustav Carus Faculty of Medicine, Technische Universität Dresden, Dresden, Germany.
Drug and alcohol dependence
|February 8, 2024
概括
甲基胺使用障碍 (MUD) 与加速的大脑衰老有关,在26-54岁的个体中显示出过早的大脑缩和白质病变. 这些变化可能会影响认知和治疗的有效性.
科学领域:
- 神经科学是一个神经科学.
- 成 药物 药物 药物 药物
- 放射学 放射学是一门学科.
背景情况:
- 全球甲基胺使用量正在增加.
- 甲胺使用与神经系统疾病如中风,帕金森症和痴呆症有关.
- 这些情况表明甲基胺可能会加速大脑衰老.
研究的目的:
- 为了调查是否有甲基胺使用障碍 (MUD) 的个人表现出加速的大脑衰老.
- 为了比较MUD患者在早期戒断期间的结构性大脑衰老指数与健康对照 (HC).
主要方法:
- 追溯性研究比较MUD (n=89) 和HC (n=89) 参与者 (年龄26-54岁).
- 对T1加权的MRI扫描分析大脑体积/脑脊液 (BV/CSF) 指数,白质超强度和状体体积.
- 使用了年龄和性别匹配的小组.
主要成果:
- 在MUD组,BV/CSF指数较低,白质过强度较大,状体体积较大 (p<0.01).
- 回归分析表明,在MUD中,BV/CSF指数和状体体积的年龄轨迹不同.
- 在老年参与者和MUD组中观察到较大的白质超强度,独立于年龄.
结论:
- 患有MUD的个体表现出过早的脑病理,包括缩和胆脉异常.
- 这种病理可能源于脑血管损伤和胆脉功能障碍.
- 在MUD中加速的大脑衰老可能会损害认知能力,并降低行为疗法的有效性.
相关概念视频
Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.
Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...


